Avail upto 30% off on all reports till July 31st.

Global Rheumatoid Arthritis Drug Market - 2016-2026 - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook

Date: Oct 24 2019
|
AllTheResearch (Featured Publisher)
|
Number of Pages: 135
|
Category: Chemical & Material

The global rheumatoid arthritis drug market was valued at US$ XX Mn in 2018 and is expected to reach US$ XX Mn by the end of the forecast period, growing at a CAGR of XX% during the period from 2019 to 2026.

The research report segments the market from a relevancy perspective into the below segments and sub-segments with quantitative analysis done from 2016 to 2026 considering 2018 as the base year for the research. Compounded Annual Growth Rate (CAGR) for each respective segment and sub-segment is calculated for the forecast period from 2019 to 2026 to provide a reference for growth potential.

Market Segments and Sub-segments Covered in the Report:

Based on Product Type rheumatoid arthritis drug market is segmented into:
Biopharmaceutical
Pharmaceuticals

Based on Application rheumatoid arthritis drug market is segmented into:
Prescription
Over-the-Counter (OTC)

Based on Geography rheumatoid arthritis drug market is segmented into:
North America (U.S. and Canada)
Europe (U.K., Germany, France, Spain, Italy and Rest of Europe)
Asia Pacific (China, Japan, India, Indonesia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)

Key Market Players Analysed and Profiled in the Study Include:
AbbVie
Boehringer Ingelheim
Novartis
Regeneron Pharmaceuticals
Pfizer
Bristol-Myers Squibb Company
Roche
UCB
Johnson & Johnson

This report covers an in-depth analysis of the rheumatoid arthritis drug market including statistical and qualitative data points with emphasis on the market dynamics including the drivers, opportunities & restraints.

There is a coverage of market dynamics at country level in the respective regional segments. The report comprises competitive analysis with focus on key players and participants of rheumatoid arthritis drug market covering in-depth data related to competitive landscape, positioning, company profiles, key strategies adopted and product-profiling with focus on market growth and potential.

Key Questions answered in the Report:

• What is the size of the overall rheumatoid arthritis drug market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the rheumatoid arthritis drug market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Market?
• What is the rheumatoid arthritis drug market size at the regional and country level?
• Who are the key market players and their key competitors?
• Market value- chain and key trends impacting every node with reference to companies
• What are the strategies for growth adopted by the key players in rheumatoid arthritis drug market?
• How does a particular company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization?
• How financially strong are the key players in rheumatoid arthritis drug market (revenue and profit margin, market capitalization, expenditure analysis, investment analysis)?
• What are the recent trends in rheumatoid arthritis drug market? (M&A, partnerships, new product developments, expansions)

Years Considered During the Study:

Historical Year: 2016 and 2017
Base Year: 2018
Forecast Period: 2019 to 2026

Chapter 1 Preface
   1.1 Report Description
          1.1.1 Purpose of the Report
          1.1.2 Target Audience
          1.1.3 USP and Key Offerings
   1.2 Research Scope
   1.3 Research Methodology
          1.3.1 Secondary Research
          1.3.2 Primary Research
          1.3.3 Expert Panel Review
          1.3.4 Approach Adopted
                1.3.4.1 Top-Down Approach
                1.3.4.2 Bottom-Up Approach
          1.3.5 Assumptions
   1.4 Market Segmentation Scope
Chapter 2 Executive Summary
   2.1 Market Summary
          2.1.1 Global Rheumatoid Arthritis Drug Market, 2016-2026, (Volume and Value)
   2.2 Market Snapshot: Global Rheumatoid Arthritis Drug Market
          2.2.1 Market Dynamics (DRO)
   2.3 Global Rheumatoid Arthritis Drug Market, by Segment, 2018
          2.3.1 Global Rheumatoid Arthritis Drug Market, by Region, 2018 (Volume and Value)
          2.3.2 Global Rheumatoid Arthritis Drug Market, by Product Type, 2018 (Volume and Value)
          2.3.3 Global Rheumatoid Arthritis Drug Market, by Application, 2018 (Volume and Value)
   2.4 Premium Insights
          2.4.1 Market In Developed Vs. Developing Economies, 2018 vs 2026
          2.4.2 Market Regional Life Cycle Analysis
          2.4.3 Pricing Analysis, by Region
                2.4.3.1 Pricing by Product
                2.4.3.2 Pricing by Applications
                2.4.3.3 Pricing by Geography/Regions
          2.4.4 Risk Factors
          2.4.5 Supply Chain Analysis and Vendor Landscaping
          2.4.6 Emerging Player Analysis
          2.4.7 Major Investments in Market
          2.4.8 Mega Trend Analysis
          2.4.9 Regulatory Analysis
          2.4.10 Key Factors Influencing Purchasing/Buying Decisions
          2.4.11 Market Pain-Points and Unmet Needs
Chapter 3 Market Dynamics
   3.1 Market Overview
   3.2 Market Driver, Restraint and Opportunity Analysis
   3.3 Market Ecosystem Analysis
   3.4 Market Trends Analysis
   3.5 Industry Value Chain Analysis
          3.5.1 Raw Material Analysis
          3.5.2 Manufacturers
          3.5.3 Profit Margin
          3.5.4 Suppliers
          3.5.5 Distribution Channel Analysis
          3.5.6 List of Key Manufacturers/Supplier
          3.5.7 List of Key/Potential Customers
          3.5.8 Technology & Innovation Landscape
          3.5.9 Patent Analysis
   3.6 Market Analysis
          3.6.1 SWOT Analysis
          3.6.2 Porter's 5 Forces Analysis
   3.7 Regulatory landscape By Region
   3.8 Analyst Views
Chapter 4 Global Rheumatoid Arthritis Drug Market, by Product Type
   4.1 Market Overview, by Product Type
          4.1.1 Incremental Opportunity, by Product Type, 2018-2026

Biopharmaceutical
Pharmaceuticals
Chapter 5 Global Rheumatoid Arthritis Drug Market, by Application
   5.1 Market Overview, by Application
          5.1.1 Incremental Opportunity, by Application, 2018-2026

Prescription
Over-the-Counter (OTC)
Chapter 6 Global Rheumatoid Arthritis Drug Market, by Region
   6.1 Market Overview, by Region
          6.1.1 Global Rheumatoid Arthritis Drug Market, by Region, 2016-2026, (Volume and Value)
   6.2 Incremental Opportunity, by Region, 2018
   6.3 North America Rheumatoid Arthritis Drug Market
          6.3.1 North America Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
          6.3.2 North America Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
          6.3.3 North America Rheumatoid Arthritis Drug Market, by Country, 2016-2026 (Volume and Value)
                6.3.3.1 U.S.
                   6.3.3.1.1 U.S. Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.3.3.1.2 U.S. Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.3.3.2 Canada
                   6.3.3.2.1 Canada Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.3.3.2.2 Canada Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
   6.4 Europe Rheumatoid Arthritis Drug Market
          6.4.1 Europe Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
          6.4.2 Europe Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
          6.4.3 Europe Rheumatoid Arthritis Drug Market, by Country, 2016-2026 (Volume and Value)
                6.4.3.1 U.K.
                   6.4.3.1.1 U.K. Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.4.3.1.2 U.K. Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.4.3.2 Germany
                   6.4.3.2.1 Germany Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.4.3.2.2 Germany Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.4.3.3 France
                   6.4.3.3.1 France Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.4.3.3.2 France Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.4.3.4 Italy
                   6.4.3.4.1 Italy Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.4.3.4.2 Italy Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.4.3.5 Spain
                   6.4.3.5.1 Spain Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.4.3.5.2 Spain Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.4.3.6 Rest of Europe
                   6.4.3.6.1 Rest of Europe Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.4.3.6.2 Rest of Europe Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
   6.5 Asia Pacific Rheumatoid Arthritis Drug Market
          6.5.1 Asia Pacific Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
          6.5.2 Asia Pacific Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
          6.5.3 Asia Pacific Rheumatoid Arthritis Drug Market, by Country, 2016-2026 (Volume and Value)
                6.5.3.1 China
                   6.5.3.1.1 China Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.5.3.1.2 China Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.5.3.2 India
                   6.5.3.2.1 India Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.5.3.2.2 India Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.5.3.3 Japan
                   6.5.3.3.1 Japan Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.5.3.3.2 Japan Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.5.3.4 Indonesia
                   6.5.3.4.1 Indonesia Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.5.3.4.2 Indonesia Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.5.3.5 Rest of Asia Pacific
                   6.5.3.5.1 Rest of Asia Pacific Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.5.3.5.2 Rest of Asia Pacific Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
   6.6 Latin America Rheumatoid Arthritis Drug Market
          6.6.1 Latin America Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
          6.6.2 Latin America Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
          6.6.3 Latin America Rheumatoid Arthritis Drug Market, by Country, 2016-2026 (Volume and Value)
                6.6.3.1 Brazil
                   6.6.3.1.1 Brazil Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.6.3.1.2 Brazil Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.6.3.2 Mexico
                   6.6.3.2.1 Mexico Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.6.3.2.2 Mexico Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.6.3.3 Rest of Latin America
                   6.6.3.3.1 Rest of Latin America Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.6.3.3.2 Rest of Latin America Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
   6.7 Middle East & Africa Rheumatoid Arthritis Drug Market
          6.7.1 Middle East & Africa Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
          6.7.2 Middle East & Africa Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
          6.7.3 Middle East & Africa Rheumatoid Arthritis Drug Market, by Region/Country, 2016-2026 (Volume and Value)
                6.7.3.1 GCC
                   6.7.3.1.1 GCC Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.7.3.1.2 GCC Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.7.3.2 South Africa
                   6.7.3.2.1 South Africa Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.7.3.2.2 South Africa Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
                6.7.3.3 Rest of Middle East & Africa
                   6.7.3.3.1 Rest of Middle East & Africa Rheumatoid Arthritis Drug Market, by Product Type, 2016-2026 (Volume and Value)
                   6.7.3.3.2 Rest of Middle East & Africa Rheumatoid Arthritis Drug Market, by Application, 2016-2026 (Volume and Value)
Chapter 7 Competitive Intelligence
   7.1 Market Players Present in Market Life Cycle
   7.2 Key Player Analysis
   7.3 Market Positioning
   7.4 Market Players Mapping, vis-à-vis Ecosystem
          7.4.1 By Segments
          7.4.2 By Region
   7.5 Strategies Adopted by Key Market Players
   7.6 Recent Developments in the Market
          7.6.1 Organic (New Product Launches, R&D, Financial, Technology)
          7.4.2 Inorganic (Mergers & Acquisitions, Partnership and Alliances, Fund Raise)
Chapter 8 Company Profiles - with focus on Company Fundamentals, Product Portfolio, Financial Analysis, Recent News and Developments, Key Strategic Instances, SWOT Analysis

AbbVie
Boehringer Ingelheim
Novartis
Regeneron Pharmaceuticals
Pfizer
Bristol-Myers Squibb Company
Roche
UCB
Johnson & Johnson
Chapter 9 About Us

Electronic files(PDF) of market research reports will be dispatched within 48-72 hours. (Mon-Fri IST)

Select License Type

Why Choose InForGrowth?
  • Customer Insights
  • Market Opportunity Mapping
  • Competitive Intelligence for Key Companies
  • Market Entry Strategy
  • Product Mix and Pricing
  • Segmentation Analysis
  • Benchmarking Research based on Ecosystem and Interconnectivity
  • Market Attractiveness Framework
  • Demand-Supply Scenario & Performance Optimization
  • Technology Landscape & Revenue Augmenting Plans
  • Impact of Circular Economy or Digital Transformation Trends
  • Region Specific Reports / Country Specific Reports for Specific Topics
  • As Per Customer Need Section Wise Reports
  • Subscription Service with Real-Time Updates
  • Access to all the Research Studies in the Chosen Domains/Verticals
  • Pre and Post-Sales Service and Support
Need Help?
+
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.